Modification of the Langendorff system of the isolated beating heart for experimental radiotherapy at a synchrotron: 4000 Gy in a heart beat
Authors:
- Elisabeth SchültkeESElisabeth Schültke
- Michael LerchMLMichael Lerch
- Timo KirschsteinTKTimo Kirschstein
- Falko LangeFLFalko Lange
- Katrin PorathKPKatrin Porath
- Stefan FiedlerSFStefan Fiedler
- Jeremy DavisJDJeremy Davis
- Jason PainoJPJason Paino
- Elette EngelsEEElette Engels
- Micah BarnesMBMicah Barnes
- Mitzi KleinMKMitzi Klein
- Christopher HallCHChristopher Hall
Open Access
- 18 May 2022
- journal article
- research article
- Published by International Union of Crystallography (IUCr) in Journal of Synchrotron Radiation
- Vol. 29 (4) , 1027-1032
Abstract
Microbeam radiotherapy could help to cure malignant tumours which are currently still considered therapy-resistant. With an irradiation target in the thoracic cavity, the heart would be one of the most important organs at risk. To assess the acute adverse effects of microbeam irradiation in the heart, a powerful ex vivo tool was created by combining the Langendorff model of the isolated beating mammalian heart with X-Tream dosimetry. In a first pilot experiment conducted at the Biomedical and Imaging Beamline of the Australian Synchrotron, the system was tested at a microbeam peak dose approximately ten times higher than the anticipated future microbeam irradiation treatment doses. The entire heart was irradiated with a dose of 4000 Gy at a dose rate of >6000 Gy s−1, using an array of 50 µm-wide microbeams spaced at a centre-to-centre distance of 400 µm. Although temporary arrhythmias were seen, they reverted spontaneously to a stable rhythm and no cardiac arrest occurred. This amazing preservation of cardiac function is promising for future therapeutic approaches.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SCHU 2589/7-1)
- Deutscher Akademischer Austauschdienst (PPP 57444927)
- Forun Rostock Faculty of Medicine (889035)
This publication has 18 references indexed in Scilit:
- Quantitative characterization of the X-ray beam at the Australian Synchrotron Imaging and Medical Beamline (IMBL)Journal of Synchrotron Radiation, 2017
- Better Efficacy of Synchrotron Spatially Microfractionated Radiation Therapy Than Uniform Radiation Therapy on GliomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- X-Tream quality assurance in synchrotron X-ray microbeam radiation therapyJournal of Synchrotron Radiation, 2016
- Radiothérapie « flash » à très haut débit de dose : un moyen d’augmenter l’indice thérapeutique par minimisation des dommages aux tissus sains ?Cancer/Radiothérapie, 2015
- γ-H2AX as a Marker for Dose Deposition in the Brain of Wistar Rats after Synchrotron Microbeam RadiationPLOS ONE, 2015
- Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in miceScience Translational Medicine, 2014
- X-Tream: a novel dosimetry system for Synchrotron Microbeam Radiation TherapyJournal of Instrumentation, 2012
- Dosimetry of intensive synchrotron microbeamsRadiation Measurements, 2011
- Retrograde heart perfusion: The Langendorff technique of isolated heart perfusionJournal of Molecular and Cellular Cardiology, 2011
- Prospects for microbeam radiation therapy of brain tumours in children to reduce neurological sequelaeDevelopmental Medicine & Child Neurology, 2007